Osteovisc™

  • Indications

    OsteoviscTM is indicated to reduce the pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and to simple analgesics (e.g., acetaminophen). It works as a lubricant and a shock absorber in knees to reduce the pain in osteoarthritis.

  • Specification

    2ml/syringe、3ml/syringe

  • Product Introduction

    Medical Sodium Hyaluronate For Intraarticular Injection (Medical sodium hyaluronate derived from bacterial fermentation) is a sterile, nonpyrogenic, non-inflammatory, transparent viscoelastic solution of highly purified sodium hyaluronate dissolved in buffered saline.
    It is indicated to reduce the pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and to simple analgesics (e.g., acetaminophen). It works as a lubricant and a shock absorber in knees to reduce the pain in osteoarthritis.
    It is sterilized by moist heat. The filled syringes are sealed aseptically.
    The product is prepared with sodium hyaluronate in physiological balance liquid, filled in pre-filled glass syringes, wherein sodium hyaluronate is prepared by microbial fermentation. The product is sterilized by terminal high-pressure steam. Single-use。

  • Quality Certification Status

    MDR (EU) 2017/745 certification will be done

注:禁忌内容或者注意事项详见说明书